The Future of Sickle Cell Care with Dr. Robert Klaassen | SCAGO Summit 2026
Sickle cell disease care is changing — but what does the future hold?
From hydroxyurea and new treatment approaches to the potential of gene therapy, groundbreaking advances are reshaping what is possible for people living with sickle cell disease.
In this conversation, we sit down with Dr. Robert Klaassen, Pediatric Hematologist/Oncologist and Hematology Physician Lead at the Children’s Hospital of Eastern Ontario (CHEO), to discuss the latest developments in sickle cell disease care and what the future may look like for patients, families, and communities.
Dr. Klaassen shares why continued research, education, self-advocacy, and strong community connections are essential to improving outcomes and transforming the sickle cell disease journey.
🎤 Dr. Klaassen will be speaking at the SCAGO Sickle Cell Summit 2026 — a gathering bringing together healthcare professionals, researchers, individuals living with sickle cell disease, families, and advocates from across the community to advance knowledge, collaboration, and care.
🎟️ Register today: https://tinyurl.com/SCAGOSummit2026
📅 August 21–22, 2026
📍 Sheraton Toronto Airport Hotel & Conference Centre
#SickleCellDisease #SCAGOSummit2026 #Hematology #GeneTherapy #Hydroxyurea #RareDisease #HealthEquity #MedicalEducation #PediatricHematology #SickleCellAwareness
0
